In clinical trials, eteplirsen was shown to be safe, and capable of increasing dystrophin levels in muscle tissue and maintaining the motor function of DMD patients.96, 97, 98, 99, 100. This evidence concerns the gene DMD and Duchenne muscular dystrophy.